About Na Homolce Hospital
Accredited by JCI (Joint Commission International), Na Homolce Hospital is one of the top hospitals in Europe and focuses on the comprehensive treatment of cardiovascular and neurological/neurosurgical diseases. Within the cardiovascular specialization, Na Homolce offers the largest range of modern and clinically verified diagnostics and treatments, including conservative treatment, minimally-invasive techniques and surgical procedures on the heart and blood vessels. Its cardiology centers includes those for the treatment of cardiac rhythm disorders, chronic heart failure, congenital heart defects, aortic disease, and valvular heart disease as well as robotic cardiac and vascular surgery. For more information visit www.homolka.cz/en-CZ/home


About CardioFocus, Inc.
CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF). The company's HeartLight Endoscopic Ablation System is commercially available at leading institutions throughout the United States and Europe. The HeartLight System is a revolutionary catheter ablation technology designed for the treatment of atrial fibrillation (AF), the most common heart arrhythmia. The HeartLight System's direct visualization, titratable laser energy, and universal balloon design make it a new standard for pulmonary vein isolation (PVI) procedures. The HeartLight System is approved for use and commercially available in the United States and Europe. More than 4,000 patients with AF have been successfully treated with the system. CardioFocus is headquartered in Marlborough, Mass.
Back to HCB News

Cardiology Homepage